Ranked among Asia’s 50 most innovative health tech start-ups for two years running, X-ZELL is fusing next-generation cell detection technology with cutting-edge AI to bring cytopathology into the digital age. The result is an accurate, affordable and globally scalable method of detecting early-stage cancers in small, 10mL blood samples.
For speaking, sponsorship and exhibition opportunities contact
jonathan.mottram@terrapinn.com
Tel: +65 6322 2738